Cargando…
Autophagy protects against dasatinib-induced hepatotoxicity via p38 signaling
Liver dysfunction is a common side effect associated with the treatment of dasatinib and its mechanism is poorly understood. Autophagy has been thought to be a potent survival or death factor for liver dysfunction, which may shed the light on a novel strategy for the intervention of hepatotoxicity c...
Autores principales: | Yang, Xiaochun, Wang, Jincheng, Dai, Jiabin, Shao, Jinjin, Ma, Jian, Chen, Chao, Ma, Shenglin, He, Qiaojun, Luo, Peihua, Yang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467432/ https://www.ncbi.nlm.nih.gov/pubmed/25749037 |
Ejemplares similares
-
Diosmetin protects against retinal injury via reduction of DNA damage and oxidative stress
por: Shen, Zeren, et al.
Publicado: (2015) -
Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin
por: Zhu, Hong, et al.
Publicado: (2014) -
Dasatinib synergises with irinotecan to suppress hepatocellular carcinoma via inhibiting the protein synthesis of PLK1
por: Xu, Li, et al.
Publicado: (2017) -
The Potential Protective Role of Naringenin against Dasatinib-Induced Hepatotoxicity
por: Alanazi, Ahmed Z., et al.
Publicado: (2023) -
PLK1 (polo like kinase 1)-dependent autophagy facilitates gefitinib-induced hepatotoxicity by degrading COX6A1 (cytochrome c oxidase subunit 6A1)
por: Luo, Peihua, et al.
Publicado: (2020)